Sheridan Capital Partners Announces Sale of Canadian Orthodontic Partners


CHICAGO, IL, April 14, 2021 – Sheridan Capital Partners (“Sheridan”) is pleased to announce the sale of Canadian Orthodontic Partners (“the Company”) to Pamlico Capital (“Pamlico”). Headquartered in Toronto and with a presence in 8 provinces, Canadian Orthodontic Partners is the largest provider of management services to orthodontic practices in Canada.

“I want to thank Sheridan for their strong support and the resources they provided to help drive our strong growth,” said Anthony Milonas, Chief Executive Officer of Canadian Orthodontic Partners. “We are proud of the organization we built and are excited to build upon this momentum as we enter our next phase of growth.”

During Sheridan’s ownership, Canadian Orthodontic Partners scaled from 5 locations in Eastern Canada to over 60 locations nationally serving more than 30,000 active patients.

“We sincerely enjoyed partnering with the Canadian Orthodontics team to build a leading, physician-centric platform”, said Jonathan Lewis of Sheridan Capital Partners. “From the outset, our shared commitment to patient experience and clinical excellence enabled us to maintain the culture and values of the Company as it scaled.”

Sean Dempsey of Sheridan Capital Partners added, “Anthony and the entire team at Canadian Orthodontic Partners have built a tremendous company whose performance since the onset of the COVID-19 pandemic highlights the continued strength of our portfolio in these challenging times.”

Blake, Cassels & Graydon LLP served as legal advisors to Sheridan.  Houlihan Lokey served as exclusive financial advisor to the Company. McDermott Will & Emery LLP served as legal advisor to Pamlico. Twin Brook Capital Partners led the debt syndication for the transaction.

The transaction was led by Jonathan Lewis, Sean Dempsey, Nicholas Rowland, and Matthew Hinshaw at Sheridan Capital Partners. Terms of the transaction were not disclosed.

About Sheridan Capital Partners

Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.

Back to News